Ugeskrift for laeger
-
Ugeskrift for laeger · Dec 2001
Review[Evidence-based grounds of physical therapy. Focus on training/exercise therapy of musculoskeletal problems].
Evidence of the benefit of exercise for patients with musculoskeletal problems was examined by analysing meta-analyses and systematic reviews. The literature search was confined to studies where pain and/or function was used as the outcome measure. ⋯ Of the systematic reviews, six out of 12 showed a positive effect and five were inconclusive, owing to the lack of clinical trials. We conclude that much more research in the field of exercise and physiotherapy is needed.
-
Ugeskrift for laeger · Dec 2001
Review[Communication and information in the Danish health services. Laws, regulations and rules for patients and personnel in the Danish health services].
This article describes communication and information between patients and health staff in the Danish Health Service. A number of laws, regulations, rights, and rules have been passed, and in 1998 a new law came into effect concerning patients' rights in the health service. ⋯ Each profession in the health service has its own regulations and ethic rules. These regulations and rules are reviewed with respect to communication and information in the Danish Health Service.
-
Ugeskrift for laeger · Dec 2001
[Measurement of quality of care and the "soft values" at a pediatric department].
Medical care must be provided in accordance with high professional standards and patients' needs and priorities. ⋯ Quality development must be implemented on a documented basis. Improvements have been implemented according to the results.
-
The aim of the study was to assess the results of a well-defined rehabilitation programme after hip arthroplasty. ⋯ A clinical programme focusing on pain relief, oral nutrition, and rehabilitation may reduce the stay in hospital and improve recovery after hip arthroplasty.
-
Ugeskrift for laeger · Dec 2001
[Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
Hydroxyurea (HU) is usually a well-tolerated antineoplastic agent, which is commonly used in the treatment of myeloproliferative disorders. Dermatological abnormalities are often seen in patients receiving long-term HU therapy. Leg ulcers have been reported occasionally. ⋯ We found a surprisingly high number of cutaneous leg ulcers in patients on HU therapy for chronic myeloproliferative disorders. We believe this disabling complication should be given greater attention and recommend that it is included in the description of the side effects of the drug.